MedRx , Ltd Receivables

The latest receivables for 4586.T is $16M as of June 2026. That compares with $15M in the prior-year period — up 2.7% year over year. Investors often review this figure alongside MedRx , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4586.T's receivables moved from $15M to $16M — a 2.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedRx , Ltd's operating scale or balance-sheet position.

A receivables figure of $16M for 4586.T is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4586.T's receivables ($16M), review year-over-year change from $15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.